Veritract, Inc.

Veritract has developed a steerable, reusable feeding tube with real-time optics to allow for fast and safe placement.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Salt Lake City, UT, USA
  • Currency USD
  • Employees 4
  • Website

Company Summary

Veritract has developed a feeding tube with integrated optics which is steerable and provides visual feedback. The SmartTube™ will enable health care providers to efficiently and routinely place nasoenteric feeding tubes at the bedside while minimizing patient exposure to radiation and risk of misplacement. The SmartTube will be the most cost-effective, efficient and safe solution for feeding tube placement.


  • John Fang

    Dr. Fang is founder and CSO of Veritract. Dr. Fang is also clinical director of the University of Utah Division of Gastroenterology, as well as a medical director of the Endoscopy Laboratory at the University of Utah Health Science Center. Dr. Fang earned his undergraduate and medical degrees at Washington University in St. Louis.

  • Hunter Jackson

    Hunter is a founder, Chairman and CEO of Navigen and CEO of Veritract. He was co-founder and served as Chairman and CEO of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) from 1986 to 2006. Hunter is a member of the Governing Authority of the Utah Science, Technology, and Research Economic Development Initiative (USTAR) and received the 1998 Ernst & Young Utah Entrepreneur of the Year Award and the 2002 Utah Governor’s Medal for Science and Technology.

  • Brandi Simpson

    Brandi is Chief Business Officer of Veritract and Navigen. She has held positions in business development and corporate strategy at NPS Pharmaceuticals. Brandi began her career as an investment banking analyst at Merrill Lynch and then worked in the life sciences practice at Booz Allen & Hamilton. She has an MBA from Stanford University and graduated from the University of Utah summa cum laude with an honors degree in finance.

  • Tim Nieman

    Tim Nieman is Chief Operating Officer of Veritract. He holds a BS in Bioengineering and has 14+ years of medical device development and design control experience. His experience includes development of technologies for cardiac surgery, vascular surgery, stent and catheter based technologies, LVADs, and laser tissue ablation devices. He has previously directed and conducted product development within the FDA regulatory environment.


  • Kevin Ontiveros, Life Sciences Law

Previous Investors

  • Founders|University of Utah Research Foundation
    Kickstart Seed Fund
    UpStart Ventures

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free